APEX Data Systems, Inc
Babcock is sounding alot like another CEO i remember from a long time ago named Brian Boner who was CEO of Warning Management Services collecting $200k a year while the company was making $1M in revs and was also the CEO of Daraldo Financial
11. Related Party Transaction
During the six months ended December 31, 2014 and 2013, the Company continued to engage the services of APEX Data Systems, Inc., owned by Dwight Babcock, the Company’s Chairman and Chief Executive Officer, to modify and maintain the Company’s web interfaced data collection application to aggregate patient data in a controlled environment. The Audit Committee and Board of Directors approved the use of the ongoing services of APEX Data Systems. Mr. Babcock recused himself from the Board vote due to his conflict of interest. The cost recorded during the six months ended December 31, 2014 and 2013 from APEX Data Systems, Inc. for the maintenance of the web interfaced data collection application was $6,000 and $9,720. An additional $6,000 was spent on the implementation and maintenance of Customer Relationship Management software during the six months ended December 31, 2014 and 2013, respectively.
i think everyone here would agree that Babcock needs to either get a partnership going or sell the company even us longs are not getting any younger
Gross Profit (loss) was (37k)
EPS is based on Operating Income or Loss which was (888k) which comes to (-0.016)
Gross Profit (37k)
Operating Income or Loss (888k)
trying to see what the net income is
At the Bio Photonic Convention, the world's Largest Biophotonics and Biomedical Optics Conference. Dwight Babcock standing in front of the Edmund Optics booth.
isoray medical facebook post 2 hours ago
IsoRay, Inc.(NYSEMKT:ISR) suffered a decline of 4.29% in value as the stock lost six cents to move to a new closing price of $1.34. The $73.54 million market cap company, which oscillated between $1.33 and $1.43 during Friday’s trading, has an earnings per share of $-0.12 and a beta of -0.97, which shows its inverse relation with the market. IsoRay, Inc has traded between $0.67 and $3.77 over the last one year and has a one year target price estimate of $5 offering plenty of upside potential but with significant short term risk.
Next EPS Date 2/18/15 *Est. EPS Growth Rate +83.3% *Last Qtr.
Average EPS % Beat Rate -8.3% Revenue Growth Rate -1.0% *Last Qtr.
Average % Move 1-Wk after EPS -2.2% Normal Earnings Time Before Open
this according to streetinsider
engadgetDOTcom/2015 / 02 / 15 / gold-nanotubes-fight-cancer / ? ncid=rss_truncated